ONVO (Organovo Holdings, Inc.) Future Price to Earnings

Corporate emblem and logo of Organovo Holdings Inc (ONVO)

Organovo Holdings, Inc. (ONVO) is growing revenues through 3D tissue printing for pharmaceutical testing, although the lack of mass-market demand keeps margin growth capped at the level of R&D costs. The company's forward P/E history visualizes this balance, where 0.00 reflects the most recent value of the metric. Ultimately, B2B contracts with industry behemoths create a foundation for recurring payments and stable cash flow.

ONVO - Organovo Holdings Projected Price to Earnings Ratio over the range 07/04/2022 - 04/24/2025

Analytical breakdowns for Organovo Holdings, Inc.

- current price and projected stock value:
General company analysis:ONVO organovo.com
Brand item of Organovo Corp

Forward P/E determines the share price relative to expected annual earnings, allowing an investor to assess whether an asset is overvalued or undervalued based on market expectations. For Organovo Holdings, Inc. (ONVO), this forward price-to-earnings ratio reflects the speculative value of R&D developments in the fight against liver fibrosis, where a declining multiple signals growing market skepticism regarding the success of clinical trials.

Competitors of Organovo Holdings, Inc. (ONVO)

Projected Price to Earnings ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Future Price to Earnings Multiple|Future Price to Earnings corcept.com CORT|RYTM - Projected Price to Earnings|Akero Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Metsera Corp|MLTX (MoonLake) - Projected Price to Earnings|CRNX: Market Cap to Future Earnings Ratio|NAMS (NewAmsterdam Pharma Corp) - Forward P/E Multiple|Forward P/E Multiple Soleno Therapeutics|Forward P/E Multiple FOLD|Future Price to Earnings ETNB (89bio Inc)|Future Price to Earnings agios.com AGIO|Structure Corp (GPCR) - Projected Price to Earnings Ratio|MDXG - Future Price to Earnings|RZLT: Future Price to Earnings|LXRX: Forward P/E Multiple|MBX - Market Cap to Projected Earnings|Future Price to Earnings Altimmune Pharma|Aardvark Pharma (AARD) - Market Cap to Projected Earnings|Future Price to Earnings sagimet.com (SGMT)|Projected Price to Earnings BioAge Labs, Inc. BIOA|Forward P/E Multiple BMEA (Biomea Fusion)|Forward Price to Earnings Multiple quincetx.com|GUTS - Future Price to Earnings|vTv Therapeutics, Inc. - Market Cap to Future Earnings Ratio|ATPC: Forward P/E Multiple|Pluri Inc (PLUR) - Forward P/E Multiple|Future Price to Earnings Synlogic, Inc.|Projected Price to Earnings Ratio Lipocine LPCN|Future Price to Earnings Matinas BioPharma Holdings Inc. (MTNB)|Projected Price to Earnings Spruce Biosciences SPRB|Galecto Corp - Projected Price to Earnings|carmellrx.com - Future Price to Earnings|LUMO - Future Price to Earnings|Future Price to Earnings Multiple RDUS (Radius Recycling Inc.)